GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » Sale Of Investment

ProKidney (MEX:PROK) Sale Of Investment : MXN7,032.11 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is ProKidney Sale Of Investment?

ProKidney's sale of investment for the three months ended in Dec. 2024 was MXN1,821.14 Mil. It means ProKidney gained MXN1,821.14 Mil from selling investments. ProKidney's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was MXN7,032.11 Mil.

Compared with last quarter (MXN2,267.93 Mil in Sep. 2024 ), ProKidney gained less money from selling investments in Dec. 2024 (MXN1,821.14 Mil).

ProKidney Sale Of Investment Historical Data

The historical data trend for ProKidney's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney Sale Of Investment Chart

ProKidney Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
- - - 2,984.38 7,798.91

ProKidney Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,283.78 1,904.82 1,038.22 2,267.93 1,821.14

ProKidney Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN7,032.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ProKidney Sale Of Investment Related Terms

Thank you for viewing the detailed overview of ProKidney's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

ProKidney Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » Sale Of Investment
Comparable Companies
ADCT SLS GLSI LYEL SNTI SLNCF EDIT SCPH KLRS NMRA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
PROK:USA
Address
2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103
Website
https://www.prokidney.com
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.